Howard Hughes Medical Institute’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-41
Closed -$13.8K 131
2025
Q4
$13.8K Hold
41
0.01% 163
2025
Q3
$12.8K Buy
41
+4
+11% +$1.18K 0.01% 171
2025
Q2
$11.1K Buy
+37
New +$10.7K ﹤0.01% 181
2016
Q4
Sell
-3,178
Closed -$257K 152
2016
Q3
$257K Buy
+3,178
New +$272K 0.07% 114

Other funds holding COR

Howard Hughes Medical Institute's COR Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Cencora (COR) in Q1 2026, closing a stake of 41 shares — an estimated $13.8K sold.

Howard Hughes Medical Institute first reported a position in COR in Q3 2016 and held it in 4 quarters. The position peaked at $257K in Q3 2016. 1,428 funds tracked by Wall St. Rank hold COR as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Cencora position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 41 Cencora shares in Q1 2026, an estimated $13.8K.
  • Howard Hughes Medical Institute first reported a position in Cencora in Q3 2016 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Cencora position peaked at $257K in Q3 2016.
  • 1,428 funds tracked by Wall St. Rank held Cencora as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.